v3.25.1
Condensed Consolidated Statements of Stockholders Equity - USD ($)
$ in Thousands
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2023   $ 3 $ 11 $ 2,594,448 $ 2,526 $ (2,012,375) $ 584,613
Beginning Balance (in Shares) at Dec. 31, 2023 194 2,842,158 256,135,715        
Stock-based compensation expense       17,773     17,773
Vesting of restricted shares issued for services (in shares)     880,242        
Tax payments related to shares retired for vested restricted stock units       (4,701)     (4,701)
Tax payments related to shares retired for vested restricted stock units (in shares)     (315,371)        
Common stock sold in public and/or at the market offering, net of offering costs     $ 1 197,360     197,361
Common stock sold in public and/or at the market offering, net of offering costs (in shares)     23,014,000        
Common stock issued upon exercise of stock options       364     364
Common stock issued upon exercise of stock options (in shares)     41,753        
Unrealized gain on investments         (69)   (69)
Foreign currency cumulative translation adjustment         (2,341)   (2,341)
Net Income (Loss)           (112,976) (112,976)
Ending Balance at Mar. 31, 2024   $ 3 $ 12 2,805,244 116 (2,125,351) 680,024
Ending Balance (in Shares) at Mar. 31, 2024 194 2,842,158 279,756,339        
Beginning Balance at Dec. 31, 2024   $ 3 $ 13 3,095,987 (1,046) (2,384,552) 710,405
Beginning Balance (in Shares) at Dec. 31, 2024 194 2,842,158 305,252,194        
Stock-based compensation expense       22,970     22,970
Vesting of restricted shares issued for services (in shares)     3,558,628        
Tax payments related to shares retired for vested restricted stock units       (5,644)     (5,644)
Tax payments related to shares retired for vested restricted stock units (in shares)     (1,387,901)        
Common stock sold in public and/or at the market offering, net of offering costs     $ 1 148,941     148,942
Common stock sold in public and/or at the market offering, net of offering costs (in shares)     25,599,389        
Common stock issued from preferred stock conversion   $ (1)   1      
Common stock issued from preferred stock conversion (in shares)   (909,491) 909,491        
Common stock issued upon exercise of stock options       15     15
Common stock issued upon exercise of stock options (in shares)     2,586        
Unrealized gain on investments         (110)   (110)
Conversion of convertible preferred stock into common stock   $ (1)   1      
Foreign currency cumulative translation adjustment         7,450   7,450
Net Income (Loss)           (116,163) (116,163)
Ending Balance at Mar. 31, 2025   $ 2 $ 14 $ 3,262,270 $ 6,294 $ (2,500,715) $ 767,865
Ending Balance (in Shares) at Mar. 31, 2025 194 1,932,667 333,934,387